Genetically altered animal models for Mas and angiotensin-(1-7).
about
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsThe ANG-(1-7)/ACE2/mas axis in the regulation of nephron functionThe role of angiotensin-(1-7) receptor Mas in spermatogenesis in mice and ratsChanges in the renin angiotensin system during the development of colorectal cancer liver metastases.Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertensionAstroglia are a possible cellular substrate of angiotensin(1-7) effects in the rostral ventrolateral medullaInhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.Salt-induced renal injury in spontaneously hypertensive rats: effects of nebivolol.Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failureAtypical signaling and functional desensitization response of MAS receptor to peptide ligands.MAS C-Terminal Tail Interacting Proteins Identified by Mass Spectrometry- Based Proteomic Approach.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice.Dose-dependent effects of angiotensin-(1-7) on the NHE3 exchanger and [Ca(2+)](i) in in vivo proximal tubules.Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart FailureAgonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism.ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease.Emerging drugs which target the renin-angiotensin-aldosterone system.Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.Renin-angiotensin system: an old player with novel functions in skeletal muscle.Validation of commercial Mas receptor antibodies for utilization in Western Blotting, immunofluorescence and immunohistochemistry studiesTargeting vasoactive peptides for managing calcific aortic valve disease.New insights into the elucidation of angiotensin-(1-7) in vivo antiarrhythmic effects and its related cellular mechanisms.Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension.Expression and cellular localization of the Mas receptor in the adult and developing mouse retina.Immunohistochemical localization of the angiotensin-(1-7) receptor Mas in the murine forebrain.Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells.Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice.Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma.Physiological and pathophysiological functions of different angiotensins in the brain.Chronic overexpression of angiotensin-(1-7) in rats reduces cardiac reactivity to acute stress and dampens anxious behavior.Increased vascular sympathetic modulation in mice with Mas receptor deficiency.Effects of ACE2 deficiency on physical performance and physiological adaptations of cardiac and skeletal muscle to exercise.Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).The renin angiotensin system and the metabolic syndrome.
P2860
Q24605072-30904539-51ED-4767-A09A-7E4C9972BFD4Q24633556-FB4AAD79-BE36-4F65-9655-A0F974316C02Q28575188-7B383187-0DF9-415A-BABD-8CD9E6A39448Q33551485-B07CF18E-7F1D-45EF-9890-E917E60DC009Q33639490-3538FE2E-050E-4BFD-B632-0E78F5B5BB34Q33997630-B8C56F21-0370-4468-AEA7-3EB62B8C3E13Q34049167-04DFC90E-1FD5-4258-9F2D-AE59AC873703Q34354558-748F5D8F-9214-4AF4-9A81-2CB623087414Q34892110-A21F87A6-9A57-4702-86F4-F030012AC714Q35214181-6DE54D0D-FFA7-4FC9-BACB-E34E432DD543Q35814372-31D029B5-F79C-433A-BE50-4D59AC253975Q36241932-6118B000-F942-4C1F-BAE7-1454D66F2AC0Q36764034-EF960A7D-93BD-4998-94EF-C20BE2115E73Q36836204-F775A649-845C-4849-9D85-B31202E93A70Q37081415-A177C809-0200-4AB2-B91C-979C6B069DACQ37147092-02348836-409F-4A9C-894A-7A1E8655F43DQ37293326-4404CF6B-A4C2-419C-9A92-4A46DC6DA79CQ37660786-B08BE235-BBFE-454F-B43E-95FA4FB4516BQ37814934-BC08DC03-C234-45E9-93AC-2C63F178DFA3Q37929786-B91260AB-9D0A-409D-B34E-04A9F0B76684Q38207841-BBF7E037-67DA-41F8-9DB1-2FC3584B8980Q38375202-78755C5F-0D0F-495A-9074-DB6709CE8ECAQ38694797-20DB12BF-574A-431F-952F-661E9020C24BQ38943935-2402F5A3-4CA2-4233-A3BC-E67E22BC3C80Q39300324-84325E40-E7D8-4109-8469-798886F3A3E4Q39586636-04485079-3362-42C2-9041-6D71681D4669Q42182698-91FF2331-47D7-4137-8C28-0194DF3D7DA8Q42502587-A149C426-72AB-4D12-B2B3-1992C0F1B5D2Q43124334-F18B89BA-A4A1-483E-8BD1-A2C4CCA7175BQ43148851-40ABF942-A4FE-4353-A2FA-F31955233486Q43476643-C8AF66F1-6204-4532-BD31-3F936B3E370BQ46322831-559A0CA2-A976-4C7F-B95E-C5BFD1DD577CQ47335475-F557C9FC-040A-4C3A-A46C-5AEB913A9BEFQ50665866-F7920324-7F76-45D0-ADA6-0C23258CFFDFQ52854048-1ED79FD6-5204-4A94-8B1C-60568073705CQ55465043-B609601E-3E4D-45ED-B61D-E7C1675CA4B2Q55473170-31D7EEF8-4DC5-4F58-8B51-90E84E9D9B7B
P2860
Genetically altered animal models for Mas and angiotensin-(1-7).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetically altered animal models for Mas and angiotensin-
@nl
Genetically altered animal models for Mas and angiotensin-(1-7).
@en
type
label
Genetically altered animal models for Mas and angiotensin-
@nl
Genetically altered animal models for Mas and angiotensin-(1-7).
@en
prefLabel
Genetically altered animal models for Mas and angiotensin-
@nl
Genetically altered animal models for Mas and angiotensin-(1-7).
@en
P2093
P2860
P1476
Genetically altered animal models for Mas and angiotensin-(1-7).
@en
P2093
Brit Rentzsch
Eugene L Patkin
Natalia Alenina
P2860
P304
P356
10.1113/EXPPHYSIOL.2007.040345
P577
2007-12-21T00:00:00Z